BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19008308)

  • 1. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action.
    Ayala JE; Bracy DP; James FD; Julien BM; Wasserman DH; Drucker DJ
    Endocrinology; 2009 Mar; 150(3):1155-64. PubMed ID: 19008308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance.
    Ayala JE; Bracy DP; James FD; Burmeister MA; Wasserman DH; Drucker DJ
    Endocrinology; 2010 Oct; 151(10):4678-87. PubMed ID: 20685876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor.
    Burmeister MA; Bracy DP; James FD; Holt RM; Ayala J; King EM; Wasserman DH; Drucker DJ; Ayala JE
    J Physiol; 2012 Oct; 590(20):5245-55. PubMed ID: 22890715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin action in the double incretin receptor knockout mouse.
    Ayala JE; Bracy DP; Hansotia T; Flock G; Seino Y; Wasserman DH; Drucker DJ
    Diabetes; 2008 Feb; 57(2):288-97. PubMed ID: 17977951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
    Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
    J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis.
    Ali S; Lamont BJ; Charron MJ; Drucker DJ
    J Clin Invest; 2011 May; 121(5):1917-29. PubMed ID: 21540554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.
    Maida A; Lamont BJ; Cao X; Drucker DJ
    Diabetologia; 2011 Feb; 54(2):339-49. PubMed ID: 20972533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.
    Smith EP; An Z; Wagner C; Lewis AG; Cohen EB; Li B; Mahbod P; Sandoval D; Perez-Tilve D; Tamarina N; Philipson LH; Stoffers DA; Seeley RJ; D'Alessio DA
    Cell Metab; 2014 Jun; 19(6):1050-7. PubMed ID: 24836562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterisation of a novel glucagon like peptide-1 receptor antibody.
    Biggs EK; Liang L; Naylor J; Madalli S; Collier R; Coghlan MP; Baker DJ; Hornigold DC; Ravn P; Reimann F; Gribble FM
    Diabetologia; 2018 Mar; 61(3):711-721. PubMed ID: 29119245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.
    Knauf C; Cani PD; Perrin C; Iglesias MA; Maury JF; Bernard E; Benhamed F; Grémeaux T; Drucker DJ; Kahn CR; Girard J; Tanti JF; Delzenne NM; Postic C; Burcelin R
    J Clin Invest; 2005 Dec; 115(12):3554-63. PubMed ID: 16322793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors.
    Hansotia T; Baggio LL; Delmeire D; Hinke SA; Yamada Y; Tsukiyama K; Seino Y; Holst JJ; Schuit F; Drucker DJ
    Diabetes; 2004 May; 53(5):1326-35. PubMed ID: 15111503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with
    Esser N; Mongovin SM; Parilla J; Barrow BM; Mundinger TO; Fountaine BS; Larmore MJ; Castillo JJ; Akter R; Hull RL; Zraika S
    Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E307-E318. PubMed ID: 35128957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents.
    Kim T; Holleman CL; Nason S; Arble DM; Ottaway N; Chabenne J; Loyd C; Kim JA; Sandoval D; Drucker DJ; DiMarchi R; Perez-Tilve D; Habegger KM
    Diabetes; 2018 Nov; 67(11):2157-2166. PubMed ID: 30150304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.
    Waget A; Cabou C; Masseboeuf M; Cattan P; Armanet M; Karaca M; Castel J; Garret C; Payros G; Maida A; Sulpice T; Holst JJ; Drucker DJ; Magnan C; Burcelin R
    Endocrinology; 2011 Aug; 152(8):3018-29. PubMed ID: 21673098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
    Scrocchi LA; Marshall BA; Cook SM; Brubaker PL; Drucker DJ
    Diabetes; 1998 Apr; 47(4):632-9. PubMed ID: 9568697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of oxyntomodulin and GLP-1 on glucose metabolism.
    Du X; Kosinski JR; Lao J; Shen X; Petrov A; Chicchi GG; Eiermann GJ; Pocai A
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E265-71. PubMed ID: 22621866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of the glucagon-like peptide-1 receptor does not affect the metabolic phenotype of mice with liver-specific G(s)α deficiency.
    Chen M; Mema E; Kelleher J; Nemechek N; Berger A; Wang J; Xie T; Gavrilova O; Drucker DJ; Weinstein LS
    Endocrinology; 2011 Sep; 152(9):3343-50. PubMed ID: 21771891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.
    Scrocchi LA; Brown TJ; MaClusky N; Brubaker PL; Auerbach AB; Joyner AL; Drucker DJ
    Nat Med; 1996 Nov; 2(11):1254-8. PubMed ID: 8898756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.